Terms: = Liver cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523
125 results:
1. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
[No Abstract] [Full Text] [Related]
2. Smart exosomes enhance PDAC targeted therapy.
Creeden JF; Sevier J; Zhang JT; Lapitsky Y; Brunicardi FC; Jin G; Nemunaitis J; Liu JY; Kalinoski A; Rao D; Liu SH
J Control Release; 2024 Apr; 368():413-429. PubMed ID: 38431093
[TBL] [Abstract] [Full Text] [Related]
3. Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis.
Drefs M; Schoenberg MB; Börner N; Koliogiannis D; Koch DT; Schirren MJ; Andrassy J; Bazhin AV; Werner J; Guba MO
Eur J Surg Oncol; 2024 Mar; 50(3):107952. PubMed ID: 38237275
[TBL] [Abstract] [Full Text] [Related]
4. Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.
Malka D; Verret B; Faron M; Guimbaud R; Caramella C; Edeline J; Galais MP; Bengrine-Lefevre L; Smith D; Dupont-Bierre E; De Baere T; Goéré D; Dartigues P; Lacroix L; Boige V; Gelli M; Pignon JP; Ducreux M
Eur J Cancer; 2023 Dec; 195():113400. PubMed ID: 37922632
[TBL] [Abstract] [Full Text] [Related]
5. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
[TBL] [Abstract] [Full Text] [Related]
6. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
[TBL] [Abstract] [Full Text] [Related]
7. A prospective head-to-head comparison of [
Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
[TBL] [Abstract] [Full Text] [Related]
8. Postoperative surveillance after surgery for colorectal liver metastasis: a cross-sectional study.
Nzenwa IC; Pathak S; Knight SR; Mowbray NG; O'Reilly D; Jones RP
Ann R Coll Surg Engl; 2024 Mar; 106(3):213-218. PubMed ID: 37218655
[TBL] [Abstract] [Full Text] [Related]
9. PathwayKO: An integrated platform for deciphering the systems-level signaling pathways.
Ai H; Meng F; Ai Y
Front Immunol; 2023; 14():1103392. PubMed ID: 37033947
[TBL] [Abstract] [Full Text] [Related]
10. Markers of inflammasome activation in Coronavirus disease 2019 (COVID-19) Egyptian patients: Impact on disease severity.
Abd El-Aty SK; Ahmed SH; Abd El-Hamid RF; Zahran AM; Magdy DM; Bakr OH; Elsherbiny NM
Egypt J Immunol; 2023 Apr; 30(2):99-108. PubMed ID: 37031411
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of genotyping in hepatocellular carcinoma: A systematic review.
Bodard S; Liu Y; Guinebert S; Yousra K; Asselah T
J Viral Hepat; 2023 Jul; 30(7):582-587. PubMed ID: 36922710
[TBL] [Abstract] [Full Text] [Related]
12. Extended therapy with [
Mader N; Nguyen Ngoc C; Kirkgöze B; Baumgarten J; Groener D; Klimek K; Happel C; Tselis N; Chun FKH; Grünwald F; Sabet A
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1811-1821. PubMed ID: 36702927
[TBL] [Abstract] [Full Text] [Related]
13. Nonalcoholic Fatty liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality.
de Avila L; Henry L; Paik JM; Ijaz N; Weinstein AA; Younossi ZM
Clin Gastroenterol Hepatol; 2023 Sep; 21(10):2588-2596.e3. PubMed ID: 36646233
[TBL] [Abstract] [Full Text] [Related]
14. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liao B; Liu Z
Int J Biol Sci; 2022; 18(15):5963-5977. PubMed ID: 36263167
[TBL] [Abstract] [Full Text] [Related]
15. KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma.
Liu J; Nie C
Anticancer Drugs; 2022 Oct; 33(9):840-849. PubMed ID: 35946516
[TBL] [Abstract] [Full Text] [Related]
16. Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast cancer Treatment.
Abbas ZS; Sulaiman GM; Jabir MS; Mohammed SAA; Khan RA; Mohammed HA; Al-Subaiyel A
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889394
[TBL] [Abstract] [Full Text] [Related]
17. Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression.
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Metastasis; 2022 Aug; 39(4):589-602. PubMed ID: 35429302
[TBL] [Abstract] [Full Text] [Related]
18. Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs.
Matsuda Y; Yamashita T; Ye J; Yasukawa M; Yamakawa K; Mukai Y; Machitani M; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Yamada S; Takei J; Kaneko MK; Kojima M; Kaneko S; Masaki T; Hirata M; Haba R; Kontani K; Kanaji N; Miyatake N; Okano K; Kato Y; Masutomi K
J Pathol; 2022 Jun; 257(2):172-185. PubMed ID: 35094384
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.
Cabiati M; Gaggini M; De Simone P; Del Ry S
Clin Exp Med; 2021 May; 21(2):269-275. PubMed ID: 33201338
[TBL] [Abstract] [Full Text] [Related]
20. From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
Chen Q; Mao R; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Cancer Med; 2020 Nov; 9(21):7849-7862. PubMed ID: 32886456
[TBL] [Abstract] [Full Text] [Related]
[Next]
